The Wellcome Trust’s Jeremy Farrar is all but begging for action to shore up the failing antibiotics market. Decades of weak investment in antibiotics has left “perilously few” companies involved in antibiotic development—a market crisis unfolding alongside the rise of deadly drug-resistant superbugs. Farrar warns that there is currently no viable pathway to market […]